El enantato de prasterona es un sintético, inyectado, profármaco de éster de larga duración de dehidroepiandrosterona (DHEA), un andrógeno débil y un neuroesteroide. Es un componente de Gynodian Depot, una formulación combinada de 4 valerato de estradiol mg y 200 mg de enantato de prasterona en aceite para inyección intramuscular de depósito normalmente una vez cada 4 semanas, that is used in the treatment of menopausal symptoms and is marketed in Europe and South America. Prasterone enanthate has an average duration of 18 days in this formulation. The pharmacokinetics of the formulation have also been assessed in other studies. The medication was patented, by Schering, en 1971.
1. Retard aging and maintain youthful vigor
2. Enhance physical fitness, improve mood and sleep, improve memory
3. Improve sexual function, increase libido
4. Regulate the immune system function, improve the body immunity
5 weight loss
6 auxiliary treatment of diseases
